NEU 1.52% $12.94 neuren pharmaceuticals limited

Will the Angelman trial be a success? Yes it will. Will Acadia...

  1. 926 Posts.
    lightbulb Created with Sketch. 354
    Will the Angelman trial be a success? Yes it will. Will Acadia continue to rely on Daybue to maintain it's wealth - Yes it will. Will several more orphan drug trials be announced by Neuren soon - Yes they will..... Will Pitt Hopkins Syndrome, Phelan McDermand Syndrome and Angelmans Syndrome be treatable with NNZ2591 soon - Yes they will.

    We are in a no news period. Hence I am accumulating more shares. Like I did last December - and I will again at the next low ebb.
    Eat, Sleep and Repeat. imho.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.